Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma: A Follow-Up Study in Patients with Absence of Aggressive Risk Factors at the Surgery of the Primary Tumor

A Marongiu, S Nuvoli, A De Vito, S Vargiu, A Spanu… - Diagnostics, 2023 - mdpi.com
Hashimoto's thyroiditis (HT) is often associated with papillary thyroid carcinoma (PC); it is
still a matter of controversy whether the behavior of carcinoma is more aggressive or not …

[HTML][HTML] The Role of Risk Factors for the Progression of Patients with T1b-T2 Papillary Thyroid Carcinoma (PC) during Long-Term Follow-Up

A Marongiu, S Nuvoli, A De Vito, A Mura… - Journal of Clinical …, 2024 - mdpi.com
Background/Objectives: Recurrence prediction for patients with PC and tumor sizes ranging
between 1 and 4 cm, classified as T1b and T2, remains a controversial problem. We …

Overweight as a biomarker for concomitant thyroid cancer in patients with Graves' disease

J Park, S An, JS Bae, JS Kim, K Kim - Frontiers in Endocrinology, 2024 - frontiersin.org
The incidence of concomitant thyroid cancer in Graves' disease varies and Graves' disease
can make the diagnosis and management of thyroid nodules more challenging. Since the …

Minimal Extrathyroid Extension (mETE) as the Only Risk Factor in Patients with Papillary Thyroid Carcinoma (PC): Its Clinical Impact on Recurrence and Outcome …

A Marongiu, S Nuvoli, A De Vito, S Vargiu, A Spanu… - Biomedicines, 2024 - mdpi.com
Minimal extrathyroid extension (mETE) effect on papillary thyroid carcinoma (PC) prognosis
is still debated even more so now that this factor has been removed in the 8th AJCC Edition …